INS and type 1 diabetes mellitus: Insulin, which has long been considered last-line therapy in the treatment of T2DM and is the primary treatment of Type 1 Diabetes Mellitus (T1DM, insulin-dependent DM), is now a viable addition to metformin as a second-line agent in lieu of sulfonylureas [6, 7].